Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lincoln, Nebraska 68502


Purpose:

The aim of this study is to evaluate the safety of the monoclonal antibody cocktail CL184 in combination with rabies vaccine compared with human rabies immune globulin (HRIG) or placebo in combination with rabies vaccine in healthy adult subjects.


Criteria:

Inclusion Criteria: - Subjects free of obvious health-problems or with stable condition - Male or female subjects aged ≥19 to ≤65 years - BMI between ≥18 and ≤30 kg/m2 Exclusion Criteria: - Prior history of active or passive rabies immunization - Clinically significant acute illness or infection within 2 weeks before first dosing based on the clinical judgment of the investigator - History and/or family history of clinically significant immunodeficiency or auto-immune disease - Any clinically significant history of known or suspected anaphylaxis or hypersensitivity reaction - Chronic administration of immunosuppressants or other immune-modifying drugs within 6 months before the first dose of investigational medicinal product


NCT ID:

NCT00656097


Primary Contact:

Principal Investigator
C. James Kissling, MD
MDS Pharma Services, 621 Rose Street, Lincoln, NE 68502, USA


Backup Contact:

N/A


Location Contact:

Lincoln, Nebraska 68502
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.